A research program devoted to the development of a new, direct dehydrative glycosylation method for the synthesis of complex oligosaccharides and glycoconjugates is proposed. The method involves in situ activation of the hemiacetal hydroxyl of a glycosyl donor with electrophilic, activated sulfoxide reagents, allowing for single step glycosylations with 1- hydroxyl glycosyl donors. Investigations into the score, mechanism, and catalytic potential of this new reaction should lead to a powerful and versatile stereoselective glycosylation reaction that can be applied to the synthesis of natural and non-natural oligosaccharides of biological utility. The application of the proposed dehydrative glycosidic coupling method to polymer-supported iterative oligosaccharide synthesis will be investigated. Successful development of this strategy should allow for single-step coupling iterations on the polymer support for the efficient construction of oligoscaccharides. Direct application of this glycosylation method for the synthesis of bioactive complex oligosaccharides is also proposed. Emphasis is directed toward the synthesis of immunostimulating agents, including: (1) the powerful adjuvant QS-21A; and (2) bioconjugatable oligosaccharides of the tumor gangliosides 9-O-acetyl-GD3 and N-glycoylyl-GM3 for potential use as subunit antigens in cancer vaccine development. The full development of this carbohydrate synthesis research program should greatly facilitate the use of these and other synthetic oligosaccharides of immunologic diagnosis and vaccine therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM058833-03
Application #
6351286
Study Section
Medicinal Chemistry Study Section (MCHA)
Program Officer
Schwab, John M
Project Start
1999-02-01
Project End
2002-01-31
Budget Start
2001-02-01
Budget End
2002-01-31
Support Year
3
Fiscal Year
2001
Total Cost
$205,310
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Karimov, Rashad R; Tan, Derek S; Gin, David Y (2018) Synthesis of the hexacyclic triterpene core of the jujuboside saponins via tandem Wolff rearrangement-intramolecular ketene hetero-Diels-Alder reaction. Tetrahedron 74:3370-3383
Karimov, Rashad R; Tan, Derek S; Gin, David Y (2017) Rapid assembly of the doubly-branched pentasaccharide domain of the immunoadjuvant jujuboside A via convergent B(C6F5)3-catalyzed glycosylation of sterically-hindered precursors. Chem Commun (Camb) 53:5838-5841
Fernández-Tejada, Alberto; Walkowicz, William E; Tan, Derek S et al. (2017) Semisynthesis of Analogues of the Saponin Immunoadjuvant QS-21. Methods Mol Biol 1494:45-71
Fernández-Tejada, Alberto; Tan, Derek S; Gin, David Y (2016) Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis. Acc Chem Res 49:1741-56
Walkowicz, William E; Fernández-Tejada, Alberto; George, Constantine et al. (2016) Quillaja Saponin Variants with Central Glycosidic Linkage Modifications Exhibit Distinct Conformations and Adjuvant Activities. Chem Sci 7:2371-2380
Blazekovic, Francesca; Odukoya, Dana; Butler, Shanitra N et al. (2016) HLA-DR peptide occupancy can be regulated with a wide variety of small molecules. Hum Vaccin Immunother 12:593-8
Fernández-Tejada, Alberto; Tan, Derek S; Gin, David Y (2015) Versatile strategy for the divergent synthesis of linear oligosaccharide domain variants of Quillaja saponin vaccine adjuvants. Chem Commun (Camb) 51:13949-52
Fernández-Tejada, Alberto; Chea, Eric K; George, Constantine et al. (2014) Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol. Bioorg Med Chem 22:5917-23
Fernández-Tejada, Alberto; Chea, Eric K; George, Constantine et al. (2014) Development of a minimal saponin vaccine adjuvant based on QS-21. Nat Chem 6:635-43
Chea, Eric K; Fernández-Tejada, Alberto; Damani, Payal et al. (2012) Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes. J Am Chem Soc 134:13448-57

Showing the most recent 10 out of 37 publications